Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid Overdose
Funded by: National Institute on Drug Abuse
Project dates: January 2019 - November 2023
Principal Investigator: Cerdá, Magdalena
Principal Investigator: Martins S

This study leverages data from the Medicaid Analytic Extract and the National Survey on Drug Use and Health to examine the independent and joint effects of cannabis legalization and prescription opioid policies on opioid use and misuse, opioid use disorder, opioid prescribing, clinic visits for chronic pain, and opioid overdoses.

Abstract on NIH RePORTER
Related Publications
Martins SS, Bruzelius E, Stingone JA, Wheeler-Martin K, Akbarnejad H, Mauro CM, Marziali ME, Samples H, Crystal S, Davis CS, Rudolph KE, Keyes KM, Hasin DS, Cerda M (2021).
Prescription opioid laws and opioid dispensing in US counties identifying salient law provisions with machine learning
Epidemiology, 32 (6), 868-876. doi: 10.1097/EDE.0000000000001404. PMCID: PMC8556655.

Hamilton L, Davis CS, Kravitz-Wirtz N, Ponicki W, Cerda M (2021).
Good Samaritan laws and overdose mortality in the United States in the fentanyl era
International of Journal of Drug Policy, 97, 103294. doi: 10.1016/j.drugpo.2021.103294.

Hasin DS, Shmulewitz D, Cerda M, Keyes KM, Olfson M, Sarvet AL, Wall MM (2020).
U.S. adults with pain, a group increasingly vulnerable to nonmedical cannabis use and cannabis use disorder: 2001-2002 and 2012-2013
American Journal of Psychiatry, 177 (7), 611-618. doi: 10.1176/appi.ajp.2019.19030284. PMCID: PMC7332392.

Kravitz-Wirtz N, Davis CS, Ponicki WR, Rivera-Aguirre A, Marshall BDL, Martins SS, Cerda M (2020).
Association of Medicaid expansion with opioid overdose mortality in the United States
JAMA Network Open, 3 (1), e1919066. doi: 10.1001/jamanetworkopen.2019.19066. PMCID: PMC6991255.